Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data

Ian Lawrance

doi:10.1038/ajg.2010.78

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data

Ian Lawrance

UWA Medical School

Research output: Contribution to journal › Article › peer-review

209 Citations (Scopus)

Original language	English
Pages (from-to)	1574-82
Journal	American Journal of Gastroenterology
DOIs	https://doi.org/10.1038/ajg.2010.78
Publication status	Published - Jul 2010

Access to Document

10.1038/ajg.2010.78

Cite this

@article{968add90aa864e4084d3d79b784dec18,

title = "Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data",

author = "Ian Lawrance",

year = "2010",

month = jul,

doi = "10.1038/ajg.2010.78",

language = "English",

pages = "1574--82 ",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data

AU - Lawrance, Ian

PY - 2010/7

Y1 - 2010/7

U2 - 10.1038/ajg.2010.78

DO - 10.1038/ajg.2010.78

M3 - Article

SN - 0002-9270

SP - 1574

EP - 1582

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

ER -